These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6887550)

  • 1. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monoclonal antibodies and cancer].
    López González JS; Selman Lama M
    Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of monoclonal antibodies to tumor diagnosis and therapy.
    Rosen ST; Winter JN; Epstein AL
    Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 5. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
    Huland E; Arndt R; Huland H
    Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The monoclonal antibody BQ16 identifies the alpha 6 beta 4 integrin on bladder cancer.
    Liebert M; Wedemeyer G; Stein JA; Washington RW; Van Waes C; Carey TE; Grossman HB
    Hybridoma; 1993 Feb; 12(1):67-80. PubMed ID: 8454305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells.
    Liebert M; Wedemeyer GA; Stein JA; Washington RW; Flint A; Ren LQ; Grossman HB
    Cancer Res; 1989 Dec; 49(23):6720-6. PubMed ID: 2479470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reactivity of monoclonal antibodies ALT-01 and ALT-04 and identification of lung cancer-associated antigens].
    Fan MZ; Qiu WR; Yu YB; Chen ZX; Cao SL; Wu RH; Wu H; Zhong JA; Ma YL; Xin YL
    Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):161-4, 9. PubMed ID: 3447854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and specificity of monoclonal antibodies against human lung carcinoma].
    Ruan ST
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Apr; 8(2):65-70, 125. PubMed ID: 4006625
    [No Abstract]   [Full Text] [Related]  

  • 10. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
    Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.
    Schlom J
    Cancer Res; 1986 Jul; 46(7):3225-38. PubMed ID: 3518915
    [No Abstract]   [Full Text] [Related]  

  • 13. [Generation and identify of a panel of monoclonal antibodies against carcinoma of the lung].
    Liu LA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):352-6. PubMed ID: 2978255
    [No Abstract]   [Full Text] [Related]  

  • 14. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
    Takahashi T; Ueda R; Song X; Nishida K; Shinzato M; Namikawa R; Ariyoshi Y; Ota K; Kato K; Nagatsu T
    Cancer Res; 1986 Sep; 46(9):4770-5. PubMed ID: 3015397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
    Fantozzi RD
    Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of monoclonal antibody (BIU-H) directed against bladder cancer and its pathologic feature].
    Guo Y
    Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):213-5, 254. PubMed ID: 1327448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro produced human antibodies in the treatment of superficial bladder cancer.
    Corrado F; Pizza G; Casanova S; De Vinci C; Fini M; Severini G; Menniti D; Corrado G
    J Exp Pathol; 1987; 3(4):347-58. PubMed ID: 3454800
    [No Abstract]   [Full Text] [Related]  

  • 18. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody therapy for cancer.
    Lovett DR; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1991; 12():147-63. PubMed ID: 1931442
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
    Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
    Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.